# US 2022/0017579 A1 · Orthogonal protein heterodimers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0017579 A1
- Document ID: US20220017579A1
- Status: Published application
- Kind: A1
- Application number: 17/482,713
- Filed: 2021-09-23
- Published: 2022-01-20
- Earliest claimed: 2018-11-02
- Applicants: University of Washington
- Inventors: Zibo CHEN; Scott BOYKEN; Sherry BERMEO; Robert A. LANGAN; David BAKER
- Web page: https://patentgrep.com/patent/US20220017579A1

## CPC

- C07K 14/435: from animals; from humans
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- B82Y 10/00: Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
- B82Y 15/00: Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
- C07K 14/00: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K 19/00: Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes}
- G01N 33/53: Immunoassay; Biospecific binding assay; Materials therefor
- G06N 3/002: {Biomolecular computers, i.e. using biomolecules, proteins, cells (using DNA G06N3/123; using neurons G06N3/061)}
- G16B 5/00: ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B 15/00: ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
- H03K 19/00: Logic circuits, i.e. having at least two inputs acting on one output (circuits for computer systems using fuzzy logic G06N7/02); Inverting circuits
- C07K 2319/00: Fusion polypeptide
- G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching
- G16B 5/10: Boolean models
- G16B 5/30: Dynamic-time models
- Y10S 977/914: Protein engineering
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- H03K: PULSE TECHNIQUE (measuring pulse characteristics G01R; modulating sinusoidal oscillations with pulses H03C; transmission of digital information H04L; discriminator circuits detecting phase difference between two signals by counting or integrating cycles of oscillation H03D3/04; automatic control, starting, synchronisation or stabilisation of generators of electronic oscillations or pulses where the type of generator is irrelevant or unspecified H03L; coding, decoding or code conversion, in general H03M)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Disclosed herein are designed heterodimer proteins, monomeric polypeptides capable of forming heterodimer proteins, protein scaffolds including such polypeptides, and methods for using the heterodimer proteins and subunit polypeptides for designing logic gates.

## Claims

### Claim at position 1

1-116. (canceled)

### Claim 117

A designed heterodimer protein, comprising a monomer A polypeptide and a monomer B polypeptide, wherein:
(a) the monomer A polypeptide and the monomer B polypeptide together comprise 4 alpha helices that interact to form the designed heterodimer protein; and
(b) central repeat units of each of the monomer A polypeptide and the monomer B polypeptide comprise a buried, asymmetric hydrogen bond network connecting all four alpha helices;
wherein:
(i) the monomer A polypeptide is a non-naturally occurring polypeptide comprising 2 alpha helices connected by an amino acid linker, and the monomer B polypeptide is a non-naturally occurring polypeptide comprising 2 alpha helices connected by an amino acid linker; or
(ii) the monomer A polypeptide is a non-naturally occurring polypeptide comprising 1 alpha helix, and the monomer B polypeptide is a non-naturally occurring polypeptide comprising 3 alpha helices connected by amino acid linkers.

### Claim 118 (depends on 117)

The designed heterodimer protein of claim 117 wherein the monomer A polypeptide is a non-naturally occurring polypeptide comprising 2 alpha helices connected by an amino acid linker, and the monomer B polypeptide is a non-naturally occurring polypeptide comprising 2 alpha helices connected by an amino acid linker.

### Claim 119 (depends on 117)

The designed heterodimer protein of claim 117 wherein the monomer A polypeptide is a non-naturally occurring polypeptide comprising 1 alpha helix, and the monomer B polypeptide is a non-naturally occurring polypeptide comprising 3 alpha helices connected by amino acid linkers.

### Claim 120 (depends on 117)

The designed heterodimer protein of claim 117 wherein the monomer A polypeptide and the monomer B polypeptide have an interaction specificity determined by four hydrogen bond networks.

### Claim 121 (depends on 117)

The designed heterodimer protein of claim 117 wherein the monomer A polypeptide and the monomer B polypeptide each comprise an effector polypeptide domain.

### Claim 122 (depends on 121)

The designed heterodimer protein of claim 121 wherein each of the effector polypeptide domains is independently selected from the group consisting of a nucleic acid binding protein, a transcription factor, a receptor binding protein, a split enzyme, and an effector of membrane receptors.

### Claim 123 (depends on 117)

The designed heterodimer protein of claim 117 wherein the monomer A polypeptide comprises a region that binds to a target A and the monomer B polypeptide comprises a region that binds to a target B.

### Claim 124 (depends on 123)

The designed heterodimer protein of claim 123 wherein a binding affinity of the monomer A polypeptide for target A is approximately equal to a binding affinity of the monomer B polypeptide for target B.

### Claim 125 (depends on 123)

The designed heterodimer protein of claim 123 wherein a binding affinity of the monomer A polypeptide for target A and a binding affinity of the monomer B polypeptide for target B are greater than a binding affinity of target A for target B.

### Claim 126 (depends on 117)

A cell comprising the designed heterodimer protein of claim 117.

### Claim 127 (depends on 126)

The cell of claim 126 wherein assembly of the designed heterodimer protein regulates a biological function of the cell.

### Claim 128 (depends on 126)

The cell of claim 126 wherein the monomer A polypeptide and the monomer B polypeptide selectively form a cognate pair and avoid binding to other non-cognate monomers of the cell.

### Claim 129 (depends on 117)

A biological cell comprising a protein logic gate comprising the designed heterodimer protein of claim 117 as a component of the protein logic gate.

### Claim 130 (depends on 129)

The protein logic gate of claim 129 provided as an AND, OR, NOT, XOR, NAND, NOR or XNOR logic gate.

### Claim 131 (depends on 117)

A transcriptional network comprising the designed heterodimer protein of claim 117 as a component of the transcriptional network.
